For example, hypermethylation of tumor suppressor genes such as PTEN and MLH1 in endometrial cancer inactivates regulatory pathways, while in ovarian cancer, abnormal BRCA1 methylation impairs DNA repair, contributing to tumor progression. This evidence concerns the gene BRCA1 and neoplasm.